451 related articles for article (PubMed ID: 17158938)
1. Role of peptide hydrophobicity in the mechanism of action of alpha-helical antimicrobial peptides.
Chen Y; Guarnieri MT; Vasil AI; Vasil ML; Mant CT; Hodges RS
Antimicrob Agents Chemother; 2007 Apr; 51(4):1398-406. PubMed ID: 17158938
[TBL] [Abstract][Full Text] [Related]
2. Rational design of alpha-helical antimicrobial peptides with enhanced activities and specificity/therapeutic index.
Chen Y; Mant CT; Farmer SW; Hancock RE; Vasil ML; Hodges RS
J Biol Chem; 2005 Apr; 280(13):12316-29. PubMed ID: 15677462
[TBL] [Abstract][Full Text] [Related]
3. Effects of net charge and the number of positively charged residues on the biological activity of amphipathic alpha-helical cationic antimicrobial peptides.
Jiang Z; Vasil AI; Hale JD; Hancock RE; Vasil ML; Hodges RS
Biopolymers; 2008; 90(3):369-83. PubMed ID: 18098173
[TBL] [Abstract][Full Text] [Related]
4. Role of helicity of α-helical antimicrobial peptides to improve specificity.
Huang Y; He L; Li G; Zhai N; Jiang H; Chen Y
Protein Cell; 2014; 5(8):631-42. PubMed ID: 24805306
[TBL] [Abstract][Full Text] [Related]
5. Comparison of biophysical and biologic properties of alpha-helical enantiomeric antimicrobial peptides.
Chen Y; Vasil AI; Rehaume L; Mant CT; Burns JL; Vasil ML; Hancock RE; Hodges RS
Chem Biol Drug Des; 2006 Feb; 67(2):162-73. PubMed ID: 16492164
[TBL] [Abstract][Full Text] [Related]
6. Rational design of α-helical antimicrobial peptides to target Gram-negative pathogens, Acinetobacter baumannii and Pseudomonas aeruginosa: utilization of charge, 'specificity determinants,' total hydrophobicity, hydrophobe type and location as design parameters to improve the therapeutic ratio.
Jiang Z; Vasil AI; Gera L; Vasil ML; Hodges RS
Chem Biol Drug Des; 2011 Apr; 77(4):225-40. PubMed ID: 21219588
[TBL] [Abstract][Full Text] [Related]
7. Effects of single D-amino acid substitutions on disruption of beta-sheet structure and hydrophobicity in cyclic 14-residue antimicrobial peptide analogs related to gramicidin S.
Lee DL; Powers JP; Pflegerl K; Vasil ML; Hancock RE; Hodges RS
J Pept Res; 2004 Feb; 63(2):69-84. PubMed ID: 15009528
[TBL] [Abstract][Full Text] [Related]
8. Transmembrane segment peptides with double D-amino acid replacements: helicity, hydrophobicity, and antimicrobial activity.
Maeda M; Melnyk RA; Partridge AW; Liu LP; Deber CM
Biopolymers; 2003; 71(1):77-84. PubMed ID: 12712502
[TBL] [Abstract][Full Text] [Related]
9. Designing α-helical peptides with enhanced synergism and selectivity against Mycobacterium smegmatis: Discerning the role of hydrophobicity and helicity.
Khara JS; Lim FK; Wang Y; Ke XY; Voo ZX; Yang YY; Lakshminarayanan R; Ee PLR
Acta Biomater; 2015 Dec; 28():99-108. PubMed ID: 26380930
[TBL] [Abstract][Full Text] [Related]
10. Studies on mechanism of action of anticancer peptides by modulation of hydrophobicity within a defined structural framework.
Huang YB; Wang XF; Wang HY; Liu Y; Chen Y
Mol Cancer Ther; 2011 Mar; 10(3):416-26. PubMed ID: 21252288
[TBL] [Abstract][Full Text] [Related]
11. Effects and mechanisms of the secondary structure on the antimicrobial activity and specificity of antimicrobial peptides.
Mai XT; Huang J; Tan J; Huang Y; Chen Y
J Pept Sci; 2015 Jul; 21(7):561-8. PubMed ID: 25826179
[TBL] [Abstract][Full Text] [Related]
12. Role of helicity on the anticancer mechanism of action of cationic-helical peptides.
Huang YB; He LY; Jiang HY; Chen YX
Int J Mol Sci; 2012; 13(6):6849-6862. PubMed ID: 22837667
[TBL] [Abstract][Full Text] [Related]
13. Structure-activity studies of 14-helical antimicrobial beta-peptides: probing the relationship between conformational stability and antimicrobial potency.
Raguse TL; Porter EA; Weisblum B; Gellman SH
J Am Chem Soc; 2002 Oct; 124(43):12774-85. PubMed ID: 12392424
[TBL] [Abstract][Full Text] [Related]
14. Origin of low mammalian cell toxicity in a class of highly active antimicrobial amphipathic helical peptides.
Hawrani A; Howe RA; Walsh TR; Dempsey CE
J Biol Chem; 2008 Jul; 283(27):18636-45. PubMed ID: 18434320
[TBL] [Abstract][Full Text] [Related]
15. Disruption of interactions between hydrophobic residues on nonpolar faces is a key determinant in decreasing hemolysis and increasing antimicrobial activities of α-helical amphipathic peptides.
Son M; Lee Y; Hwang H; Hyun S; Yu J
ChemMedChem; 2013 Oct; 8(10):1638-42. PubMed ID: 23894079
[TBL] [Abstract][Full Text] [Related]
16. Peptide hydrophobicity controls the activity and selectivity of magainin 2 amide in interaction with membranes.
Wieprecht T; Dathe M; Beyermann M; Krause E; Maloy WL; MacDonald DL; Bienert M
Biochemistry; 1997 May; 36(20):6124-32. PubMed ID: 9166783
[TBL] [Abstract][Full Text] [Related]
17. Effects of hydrophobicity on the antifungal activity of alpha-helical antimicrobial peptides.
Jiang Z; Kullberg BJ; van der Lee H; Vasil AI; Hale JD; Mant CT; Hancock RE; Vasil ML; Netea MG; Hodges RS
Chem Biol Drug Des; 2008 Dec; 72(6):483-95. PubMed ID: 19090916
[TBL] [Abstract][Full Text] [Related]
18. Design and synthesis of amphiphilic alpha-helical model peptides with systematically varied hydrophobic-hydrophilic balance and their interaction with lipid- and bio-membranes.
Kiyota T; Lee S; Sugihara G
Biochemistry; 1996 Oct; 35(40):13196-204. PubMed ID: 8855958
[TBL] [Abstract][Full Text] [Related]
19. Design of an α-helical antimicrobial peptide with improved cell-selective and potent anti-biofilm activity.
Zhang SK; Song JW; Gong F; Li SB; Chang HY; Xie HM; Gao HW; Tan YX; Ji SP
Sci Rep; 2016 Jun; 6():27394. PubMed ID: 27271216
[TBL] [Abstract][Full Text] [Related]
20. Effect of preferred binding domains on peptide retention behavior in reversed-phase chromatography: amphipathic alpha-helices.
Zhou NE; Mant CT; Hodges RS
Pept Res; 1990; 3(1):8-20. PubMed ID: 2134049
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
